| Relation | Metric | Value | YoY |
|---|
Where did the money come from, and where was it spent?
Current data explains this period's structure but is insufficient for a year-over-year conclusion.
- Revenue
- USD 35.69B YoY −0.74%
- Largest revenue segment share (Eliquis)
- 30.79%
- Cost of revenue
- USD 9.84B Share 27.57% · YoY +7.46%
- Research and development
- USD 7.37B Share 20.63% · YoY −7.57%
View calculation evidence
YoY periods: 9M 2025 compared with 9M 2024
Source metrics
- Research and developmentResearch and development · ResearchAndDevelopmentExpense
- Largest revenue segment share (Eliquis)Eliquis · segment_value / revenue * 100
- RevenueTotal revenues · Revenues
- Cost of revenueCost of products sold · CostOfGoodsAndServicesSold